Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 52.03% | 8.07% | -47.85% | -37.46% | 5.59% |
| Total Receivables | 104.31% | -27.13% | -33.65% | -14.69% | 18.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.90% | 2.14% | -56.33% | -0.25% | -42.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -1.64% | 75.33% | 76.90% | -71.92% |
| Total Current Assets | 51.40% | 7.01% | -47.15% | -35.64% | 1.22% |
|
|
|||||
| Total Current Assets | 51.40% | 7.01% | -47.15% | -35.64% | 1.22% |
| Net Property, Plant & Equipment | 4.26% | -37.06% | -33.32% | -30.68% | -28.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 50.41% | 6.10% | -46.86% | -35.54% | 0.36% |
|
|
|||||
| Total Accounts Payable | 192.18% | 95.16% | 290.92% | 38.04% | -51.47% |
| Total Accrued Expenses | 12.79% | 125.22% | 79.64% | 443.13% | 108.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.31% | -17.01% | -9.17% | -2.34% | 4.58% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 72.03% | 100.15% | 103.26% | 213.87% | 12.46% |
|
|
|||||
| Total Current Liabilities | 72.03% | 100.15% | 103.26% | 213.87% | 12.46% |
| Long-Term Debt | 7.20% | 7.19% | 7.19% | 7.19% | 7.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.33% | -48.20% | -44.55% | -41.96% | -40.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.14% | 14.58% | 13.81% | 21.27% | 6.67% |
|
|
|||||
| Common Stock & APIC | 27.20% | 15.92% | 1.79% | 1.82% | 11.31% |
| Retained Earnings | -17.16% | -16.33% | -16.06% | -15.44% | -12.73% |
| Treasury Stock & Other | 4.85% | 4.85% | 0.00% | 0.00% | 9.53% |
| Total Common Equity | 217.71% | -14.62% | -155.49% | -115.34% | -21.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 217.71% | -14.62% | -155.49% | -115.34% | -21.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 217.71% | -14.62% | -155.49% | -115.34% | -21.61% |
|
|
|||||